Clariant AG (CLZNF) Receives a Buy from Kepler Capital

By Jason Carr

Kepler Capital analyst Christian Faitz maintained a Buy rating on Clariant AG (CLZNFResearch Report) on October 14 and set a price target of CHF20.00. The company’s shares closed last Wednesday at $19.00.

According to, Faitz is a 1-star analyst with an average return of -1.3% and a 44.4% success rate. Faitz covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, LANXESS, and Solvay.

Currently, the analyst consensus on Clariant AG is a Moderate Buy with an average price target of $20.23.

See today’s analyst top recommended stocks >>

The company has a one-year high of $22.20 and a one-year low of $15.11. Currently, Clariant AG has an average volume of 42.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals; Catalysis; Natural Resources;Plastics and Coatings; and Corporate. The Care Chemicals segment comprises the industrial and consumer specialties business unit (BU), food additives as well as the industrial biotechnology business. The Catalysis segment develops, manufactures, and sells a catalyst product for the chemical, fuel, and automotive industries. The Natural Resources segment comprises BUs oil and mining services and functional minerals. The Plastics and Coatings segment includes the BUs additives, pigments, and masterbatches. The company was founded in 1995 and is headquartered in Muttenz, Switzerland.